As GLP-1s become easier to access outside a doctor’s office, the conversation around them is getting harder to navigate. Microdosing is just one trend gaining attention, but how much of what you’re hearing actually holds up? Two Michigan Medicine specialists separate the growing buzz from what’s really known.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.